Histopathological Spectrum of Thyroidectomy Specimens and Clinicopathological Characteristics of Thyroid Malignancy in Mogadishu, Somalia: A Retrospective Cross-Sectional Study Authors: Mohamed Serar Yusuf, Mohamed Mustaf Ahmed, Rahma Mohamed Ali, Abdkerem Abdulahi Abdi Published: 2026 ABSTRACT AbstractBackgroundThyroid cancer incidence is rising globally; however, histopathological data from Somalia are scarce, and no comprehensive characterization of resected thyroid specimens has been reported.MethodsA retrospective review of 438 thyroidectomy specimens reported at a histopathology referral laboratory in Mogadishu, Somalia, between 2022 and 2025 was performed. Each specimen was classified as benign, borderline, or malignant according to the World Health Organization criteria. The associations between malignancy and age and sex were examined using chi-square or Fisher exact tests and unadjusted logistic regression.ResultsThe cohort was predominantly female (90%), with a median age of 37 years. Benign lesions accounted for 366 specimens, borderline lesions for 8, and malignant lesions for 64, giving an overall malignancy proportion of 14.6%. Nodular and colloid goiters dominated the benign diagnoses, and papillary thyroid carcinoma was the most frequent malignant subtype, accounting for 50 of 64 cases. Malignancy was highest in patients aged 30 years or younger (22.2%), and the variation across age groups was statistically significant. The incidence of malignancy did not differ significantly according to sex. Among malignant tumors, the median size was 3.0 cm, and most were in the early tumor category.ConclusionBenign goiter dominates thyroid surgical pathology in Mogadishu, while papillary carcinoma leads to a modest malignant burden that is proportionally greatest in younger patients. Strengthening pathology capacity, preoperative cytology, and cancer surveillance is therefore warranted.Keywords: thyroid neoplasms, histopathology, goiter, Somalia, papillary thyroid carcinoma Background Thyroid cancer has become one of the most rapidly increasing cancer diagnoses worldwide, and its epidemiological profile has shifted markedly toward younger populations over the past two decades.1 In 2022, approximately 237,000 new cases arose among adolescents and young adults worldwide, with an estimated 239,362 cases among individuals aged < 40 years. This places thyroid cancer among the three most frequently diagnosed cancers in 100 countries for women and 26 countries for men, making it the second most common cancer in individuals under 40 years of age, irrespective of sex.1,2 Asia now carries the largest share of the global burden, accounting for 72.7% of cases in 2022, with an age-standardized incidence of 10.7 per 100,000 and an age-standardized mortality of only 0.5 per 100,000.3 Much of this increase has been attributed to the overdiagnosis of small and biologically indolent papillary tumors detected through expanding access to imaging and cytology.2,4 The incidence varies greatly by country, continent, and human development index, whereas mortality is far less variable,1 and the same dissociation is visible in Europe, where thyroid cancer has a relatively high age-standardized incidence of 7.5 per 100,000 with a mortality of 0.21 per 100,000.5 This pattern reflects the influence of diagnostic intensity and health system infrastructure rather than underlying biological risks alone. A consistent and well-documented feature of the disease is its female preponderance, with thyroid cancer occurring approximately three times more often in women than in men.6,7 The burden and presentation of thyroid disease differ substantially in much of sub-Saharan Africa, where iodine deficiency remains widespread,8 and benign goitrous conditions continue to dominate surgical pathology. An estimated two billion people have insufficient iodine intake, and populations in South Asia and sub-Saharan Africa remain among the most severely affected.9 Endemic goiter persists in parts of West Africa, even where median urinary iodine concentrations appear adequate, with goiter detected in nearly three-quarters of schoolchildren in one West African survey.10 Histopathological series from across the continent consistently report that hyperplastic and colloid goiters account for the majority of thyroidectomy specimens, neoplasms form a minority, and papillary thyroid carcinoma (PTC) is the most frequent malignant subtype.11,12 These series also describe a striking female predominance, with female-to-male ratios of about 5 to 1 in Nigeria and 3 1 in Ethiopia, and a mean age at diagnosis in the fifth decade of life.13,14 An apparent global increase in thyroid cancer incidence has been observed on every continent except Africa, where detection is widely judged to be insufficient and where the true magnitude of the disease is likely underestimated.13 Considering this continental background, Somalia represents a particularly under documented setting in which the available description of the national cancer burden rests on hospital-based pathology series rather than on a population-based cancer registry.15 The limited available data suggest that thyroid cancer constitutes a small but recognizable share of the national cancer burden, accounting for roughly three percent of malignancies in one hospital-based series from Mogadishu.15 The principal existing Somali study on thyroid disease relied on fine-needle aspiration cytology (FNAC), which demonstrated high diagnostic accuracy and a marked female predominance among patients with thyroid lesions.16 A comprehensive histopathological characterization of resected thyroid specimens, including the full diagnostic spectrum and clinicopathological features of malignant tumors, has not been previously reported for this population.16 This gap is compounded by the recent revision of diagnostic standards, as the fifth edition of the World Health Organization (WHO) classification of thyroid tumors recognizes a family of low-risk or borderline neoplasms, including non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), which have important implications for how indolent lesions are counted and managed, but have not yet been applied to Somali surgical material.17,18 Closing this gap is important for clinical care, surgical planning, and the development of national cancer surveillance, because reliable local data on the histopathological spectrum and age and sex distribution of malignancy are prerequisites for risk-adapted diagnosis and treatment.19 Characterizing which lesions are resected, how often malignancy is encountered, and which patients are most likely to harbor cancer can inform the rational use of preoperative cytology and the choice of surgical procedure in a resource-limited environment.16,19 Evidence from the wider endocrine surgical literature reinforces that the operation itself is only one component of care and that structured postoperative biochemical monitoring is required to detect the metabolic and micronutrient disturbances that may follow endocrine surgery, as has been shown for homocysteine, vitamin B12, and folate after bariatric metabolic surgery.20 Such information also provides a baseline against which the effects of iodine nutrition, evolving diagnostic capacity, and changing referral patterns can be measured.8 This study aimed to characterize the histopathological spectrum of thyroidectomy specimens and the clinicopathological features of thyroid malignancy and to examine the association of malignancy with patient age and sex among patients who underwent thyroid surgery in Mogadishu, Somalia, between 2022 and 2025. Methods Study Design and Setting This retrospective study reviewed thyroidectomy histopathology records from the Nova Diagnostic Center, Mogadishu, Somalia, a private histopathology referral laboratory that processes and reports surgical pathology specimens received from multiple public and private hospitals in Mogadishu. Histopathology reports issued between January 2022 and March 2025 were the primary data source. The laboratory received specimens from 26 distinct referring centers. The referral volume was highly concentrated. Shaafi Hospital contributed 328 of the 438 specimens (74.9%), followed by Somali Sudanese Hospital with 19 specimens (4.3%), Royal Hospital with 13 (3.0%), and Somali Turkey Hospital with 12 (2.7%), while each of the remaining centres contributed fewer than 10 specimens. One referring center, Galkayo Medical Hospital, is located outside Mogadishu and contributed one specimen. A further 7 specimens (1.6%) were submitted directly to the laboratory rather than through a referring center, and the referring center was not recorded for 1 specimen. Therefore, the referral network reflects the surgical caseload of the centers that use this laboratory rather than a defined population catchment. Population, Eligibility, and Sampling The study population comprised patients whose thyroidectomy specimens were examined at the Nova Diagnostic Center during the study period. Eligible records included all consecutive thyroidectomy specimens with a complete final histopathological diagnosis, limited to one record per patient. Duplicate records, non-thyroid surgical specimens, consultation slides without complete clinicopathological information, records lacking a final histopathological diagnosis, and records with irretrievable essential data that prevented reliable classification were excluded from the study. Convenience sampling was used, and every eligible specimen received during the study period was included. A total of 438 eligible thyroidectomy specimens were analyzed. Variables and Operational Definitions The extracted data included patient age, sex, year of surgery, surgical procedure, specimen size, laterality, histopathological diagnosis, tumor subtype, tumor size, capsular invasion, vascular invasion, lymph node metastasis, extrathyroidal extension, margin status, and tumor stage. Histopathological diagnoses were classified as benign, borderline, or malignant according to the fifth edition of the WHO Classification of Tumors of Endocrine Organs.17 NIFTP and well-differentiated tumors of uncertain malignant potential (WDT-UMP) were classified as borderline lesions; this category corresponds to the low-risk neoplasm family of the fifth edition, and the term borderline is used throughout this article. Thyroid function was defined as preoperative serum thyroid-stimulating hormone (TSH), free thyroxine (free T4), and/or free triiodothyronine (free T3) levels recorded on accompanying clinical request forms or in hospital records, where available. Clinical outcomes were defined as documented postoperative outcomes, recurrence, follow-up status, or mortality in hospital records. Because thyroid function and clinical outcome data were unavailable for almost all patients, these variables were excluded from the statistical analyses to minimize information bias. Data Sources and Data Collection Data were abstracted from the laboratory information system, pathology request forms, and final histopathology reports using a standardized data abstraction form by the principal investigator and entered a structured electronic database. To ensure data quality, a second reviewer independently verified a random sample of records, and discrepancies were resolved using the original pathology reports. Logical consistency checks and duplicate record screening were performed before the statistical analysis. Bias and Confounding Selection bias may have arisen because the study included only surgically treated patients referred to the Nova Diagnostic Center and, therefore, may not represent all thyroid diseases in Somalia. Referral bias is also possible because the laboratory serves tertiary referral hospitals, and incomplete retrospective records may have introduced information bias. These risks were mitigated by including consecutive eligible cases, applying standardized WHO diagnostic criteria, following a predefined abstraction protocol, independently verifying a sample of records, removing duplicate records, and reporting missing data without imputation. Sample Size Rationale No formal sample size or power calculations were performed. All thyroidectomy specimens that were available during the study period and met the eligibility criteria were included, resulting in a total of 438 specimens. Statistical Analysis Plan Statistical analyses were performed using R (version 4.5.1). Categorical variables were summarized as counts and percentages, and continuous variables were summarized as medians with interquartile ranges or means with standard deviations, as appropriate for their distribution. The primary classification of interest was the histopathological category of each specimen: benign, borderline, or malignant. Associations between malignancy and categorical patient characteristics were examined using the chi-square test or Fisher’s exact test, as appropriate, for the expected cell counts. The association between age and malignancy was examined using unadjusted logistic regression, from which odds ratios (ORs) and 95% confidence intervals (CIs) were obtained. Values recorded as not reported or not applicable were treated as missing and not imputed. A sensitivity analysis was performed to compare the three-level classification with a two-level classification in which borderline lesions were reassigned. All tests were two-sided, and a p-value below 0.05 was considered statistically significant. Results Cohort Characteristics A total of 438 thyroidectomy specimens were analyzed in this study. The mean age was 39.5 years with a standard deviation of 15.3 years, and the median age was 37.0 years with an interquartile range of 28.0 to 49.0 years, across a range of 8–93 years. Patients aged 30 years or younger comprised the largest group (153 specimens, 35%), followed by 149 specimens (34%) aged 31–45 years, 94 specimens (21%) aged 46–60 years, and 42 specimens (9.6%) older than 60 years. Female patients predominated, accounting for 393 specimens (90%), compared with 45 specimens (10%) from male patients. The specimens spanned the years 2022 to 2025, with 24 specimens (5.5%) in 2022, 166 specimens (38%) in 2023, 214 specimens (49%) in 2024, and 34 specimens (7.8%) in 2025. Total thyroidectomy was the predominant procedure, accounting for 429 specimens (98%), whereas subtotal or near-total thyroidectomy, lobectomy or hemithyroidectomy, and other or unspecified procedures each accounted for three specimens (0.7%). The largest specimen dimension had a median of 5.5 cm, with an interquartile range of 4.5–7.0 cm and was not reported for 20 specimens (Table 1). Table 1Baseline Characteristics of the Study CohortCharacteristicTotal (N = 438)Age, years Mean (SD)39.5 (15.3) Median (Q1, Q3)37.0 (28.0, 49.0)Age group, years ≤30153 (35%) 31 to 45149 (34%) 46 to 6094 (21%) Older than 6042 (9.6%)Sex Female393 (90%) Male45 (10%)Specimen year 202224 (5.5%) 2023166 (38%) 2024214 (49%) 202534 (7.8%)Surgical procedure Total thyroidectomy429 (98%) Subtotal or near total thyroidectomy3 (0.7%) Lobectomy or hemithyroidectomy3 (0.7%) Other or not specified3 (0.7%)Largest specimen dimension, cm Median (Q1, Q3)5.5 (4.5, 7.0) Not reported20Notes: Data are presented as n (%) unless otherwise indicated. SD denotes standard deviation; Q1 and Q3 denote the first and third quartiles. Percentages are based on the total of 438 specimens. Baseline Characteristics of the Study Cohort Notes: Data are presented as n (%) unless otherwise indicated. SD denotes standard deviation; Q1 and Q3 denote the first and third quartiles. Percentages are based on the total of 438 specimens. Histopathological Diagnostic Spectrum Benign lesions accounted for most diagnoses, with 366 specimens, 8 specimens classified as borderline, and 64 as malignant. Among the benign lesions, nodular or multinodular goiter was the most frequent at 198 specimens, followed by colloid goiter at 104 specimens, thyroiditis at 38 specimens, follicular adenoma at 23 specimens, and other benign lesions at 3 specimens. The eight borderline lesions comprised seven cases of NIFTP and one case of WDT-UMP. Among the malignant tumors, PTC was the most common, with 50 specimens, followed by follicular thyroid carcinoma (FTC) with 8 specimens, carcinoma of unspecified subtype with 5 specimens, and anaplastic thyroid carcinoma with 1 specimen (Figure 1). Histopathological diagnostic spectrum of the 438 thyroidectomy specimens across the benign, borderline, and malignant categories. Clinicopathological Features of Malignant Tumors Among the 64 malignant tumors, the median tumor size was 3.0 cm, with an interquartile range of 2.0–4.8 cm, and the tumor size was not reported for one case. Tumor laterality was right in 25 (57%), bilateral in 12 (27%), and left in 7 (16%), with laterality not reported for 20 cases. Capsular invasion was present in 16 of the 33 evaluable cases (48%) and was not reported in 31 cases. Vascular invasion was present in 5 of 51 evaluable cases (9.8%) and was not reported in 13 cases, whereas lymph node metastasis was present in 1 of 29 evaluable cases (3.4%) and was not reported in 35 cases. Extrathyroidal extension was present in 4 of 55 evaluable cases (7.3%) and was not reported in 9 cases. Surgical margins were negative in 51 (94%) cases and positive in 3 (5.6%) cases, with margin status not reported for 10 cases. The T category was T1 in 20 cases (32%), T2 in 25 cases (40%), and T3 in 17 cases (27%), with no T4 tumors and the T category not reported for two cases. The percentages for each feature were based on evaluable cases, that is, those in which the feature was assessed and reported. Nodal and distant metastasis status could not be assigned in most cases; therefore, no complete tumor, node, and metastasis (TNM) stage was reported (Table 2). Table 2Clinicopathological Features of the Malignant Thyroid TumoursFeatureEvaluable Cases, nMalignant Cases (N = 64)Tumour size, cm63 Median (Q1, Q3)3.0 (2.0, 4.8) Not reported1Laterality44 Right25 (57%) Left7 (16%) Bilateral12 (27%) Not reported20Capsular invasion33 Present16 (48%) Not reported31Vascular invasion51 Present5 (9.8%) Not reported13Lymph node metastasis29 Present1 (3.4%) Not reported35Extrathyroidal extension55 Present4 (7.3%) Not reported9Margin status54 Negative51 (94%) Positive3 (5.6%) Not reported10T category62 T120 (32%) T225 (40%) T317 (27%) T40 (0%) Not reported2Notes: Data are presented as n (%) unless otherwise stated. Percentages were calculated using evaluable cases only, with missing values reported separately. Q1 and Q3 represent the first and third quartiles. Missing data reflect incomplete reporting in narrative pathology records. Lymph node status was assessable only when nodal tissue was submitted; therefore, complete TNM staging could not be determined, and only the T category is reported. Clinicopathological Features of the Malignant Thyroid Tumours Notes: Data are presented as n (%) unless otherwise stated. Percentages were calculated using evaluable cases only, with missing values reported separately. Q1 and Q3 represent the first and third quartiles. Missing data reflect incomplete reporting in narrative pathology records. Lymph node status was assessable only when nodal tissue was submitted; therefore, complete TNM staging could not be determined, and only the T category is reported. Malignancy in Relation to Age and Sex The overall proportion of malignant tumors was 14.6%, corresponding to 64 of 438 specimens. Malignancy varied across age groups, with the highest proportion of 22.2% in patients aged 30 years or younger, falling to 10.1% in those aged 31–45 years and 8.5% in those aged 46–60 years, and rising again to 16.7% in those older than 60 years. This variation across age groups was statistically significant, with a chi-square p-value of 0.006. In the unadjusted logistic regression, increasing age was associated with lower odds of malignancy, with an odds ratio of 0.84 per 10 years of age, a 95% confidence interval of 0.70–1.01, and a p-value of 0.074. The proportion of malignant tumors was 14.2% among female patients (56 of 393) and 17.8% among male patients (8 of 45), a difference that was not statistically significant, with a Fisher exact p value of 0.507 and an odds ratio for male compared with female patients of 1.30 and a 95% confidence interval of 0.54 to 2.81 (Figure 2). Malignancy rate by age group and by sex among the 438 thyroidectomy specimens. Discussion In this retrospective series of thyroidectomy specimens from Mogadishu, benign goitrous disease accounted for most of diagnoses, malignant tumors formed a clear minority dominated by PTC, and the cohort was overwhelmingly female. Malignancy was more frequent among younger patients and showed no significant association with sex. The introduction of borderline diagnostic categories had a small effect on the overall malignancy estimate. The predominance of nodular and colloid goiter is consistent with reports from other African centers and is in keeping with a setting where iodine deficiency and endemic goiter remain important drivers of thyroid surgery.11,12 Hyperplastic lesions accounted for 76.6% of diagnoses in a recent Nigerian series, close to the 68.9% of specimens in the present cohort that were nodular or colloid goiters. A large Ethiopian thyroidectomy cohort similarly found that PTC dominated malignant tumors, with variations across series most plausibly reflecting differences in case selection and referral thresholds.11,14 Persisting iodine insufficiency across sub-Saharan Africa plausibly contributes to the large goiter burden and the late presentation of bulky glands that are removed for compressive or cosmetic reasons.9,10 Under the fifth edition of the WHO classification, much of this benign nodular disease is now grouped as thyroid follicular nodular disease, a change in terminology that should be reflected in local reporting practices.17,21 The overall malignancy frequency of approximately one in seven resected specimens falls within the broad range described for African thyroidectomy and biopsy series, which is plausibly explained by the fact that only operated glands were examined and that preoperative selection concentrates on higher-risk lesions among those sent for surgery.13,16 A 15-year Nigerian review of thyroid biopsies found malignancy in approximately one-tenth of specimens, whereas an Ethiopian series of operated nodular disease reported malignancy in a share comparable with the present surgical estimate, illustrating how the choice of denominator, whether all biopsies or only resected glands, shapes any reported malignancy rate.13,14 PTC was the leading malignant subtype, which aligns with the global shift toward papillary histology and contemporary African data.12,13 The relatively substantial share of FTC compared with high-income settings may reflect the influence of iodine deficiency on tumor histology, since correction of iodine deficiency has been associated with a declining proportion of FTC in formerly deficient populations, consistent with the persisting iodine insufficiency documented across sub-Saharan Africa, although ascertainment differences could equally contribute.9,22 The identification of borderline lesions, comprising NIFTP and WDT-UMP, represents an early application of the revised WHO framework to Somali surgical samples.17,21 Recognizing these indolent entities is important because their reclassification was explicitly intended to reduce overtreatment, and a sensitivity analysis confirmed that reassigning them altered the malignancy estimate only marginally.4,18 The overwhelming female predominance is consistent with the well-established sex disparity in thyroid disease, although the proportion of women in this surgical cohort exceeded the threefold excess usually reported and probably reflects local referral and health-seeking patterns in addition to underlying biology.6,7 Although male sex was not significantly associated with malignancy in this cohort, the slightly higher malignant fraction among men is consistent with evidence that male patients tend to present with more advanced and aggressive disease.7,23 The observation that malignancy was most frequent in the youngest patients, declining across middle age before a modest rise in the oldest group, is striking and contrasts with the rising absolute incidence of thyroid cancer across middle age; however, it is concordant with the disproportionate contribution of thyroid cancer to malignancy in adolescents and young adults and with reports that women with thyroid cancer present at younger ages.1,14 A plausible explanation is that benign goiter accumulates with advancing age and enlarges the denominator of older operated patients, so that a malignant diagnosis becomes proportionally less common even as the absolute number of cancers does not fall.2,11 The clinicopathological features of malignant tumors suggest that the disease is detected at a more advanced local stage than is typical of high-income settings dominated by incidentally discovered microcarcinomas.4,24 The median tumor size of several centimeters and the predominance of tumors staged beyond the smallest category point to later presentation and limited opportunistic detection, in contrast with the microcarcinoma-driven overdiagnosis seen elsewhere.1,4 Capsular invasion was present in roughly half of the assessed tumors, a feature central to the diagnosis of follicular-patterned malignancy under current criteria, whereas lymph node metastasis and extrathyroidal extension were documented infrequently, which may indicate genuinely lower rates or, more likely, incomplete pathological assessment and nodal sampling.21,25 Because even minimal extrathyroidal extension is a recognized risk factor for recurrence, its apparent rarity should be interpreted cautiously, given the extent of missing data.23,25 The near-universal use of total thyroidectomy indicates an extensive surgical approach that diverges from the increasing international preference for lobectomy in appropriately selected low-risk disease, although the high rate of negative margins indicates that the resections were generally complete.19,24 Several limitations should be considered when interpreting the findings of this study. The study was retrospective and drew on existing pathology records; therefore, the analysis was constrained by the quality and completeness of those records. Because the specimens were identified through referral-based surgical pathology, the cohort may not be representative of the underlying population, and the marked female predominance may reflect referral and health-seeking patterns rather than the actual surgical population. Many malignant tumor characteristics, including capsular and vascular invasion, lymph node status, extrathyroidal extension, and laterality, were not reported in a substantial proportion of cases; therefore, the prevalence of these features could not be estimated reliably, and the staging derived from recorded information is likely incomplete. Thyroid function and clinical outcomes were absent from almost all records and could not be analyzed, no central histopathological review or independent re-reading was undertaken, and no measure of iodine status was available. The study period was short, and the annual case counts were uneven, with 24 specimens in 2022, 166 in 2023, 214 in 2024, and 34 in the first quarter of 2025. This distribution reflects case ascertainment rather than changes in the occurrence of thyroid disease. The number of distinct referring centers rose from 6 in 2022 to 18 in 2023 and stood at 16 in 2024 as the laboratory became an established referral histopathology provider. Thus, the sharp increase in 2024 most plausibly represents the first full calendar year in which the expanded referral network operated at a steady state, whereas the 2025 figure covers only January to March. Therefore, the annual counts in this series should not be read as an incidence trend. The absence of a population denominator means that the incidence and true population risk could not be determined. These findings have several implications for practice, policy, and research. Strengthening histopathological capacity and adopting standardized synoptic reporting aligned with the fifth edition of the WHO classification would improve the completeness and comparability of thyroid pathology in Somalia.17,21 Wider and more consistent use of preoperative FNAC with the Bethesda system could refine patient selection and reduce unnecessary thyroid surgery for benign diseases.16,19 As diagnostic capacity matures, risk-adapted surgery and consideration of active surveillance for low-risk papillary microcarcinoma may help avoid overtreatment of indolent tumors.19,24 At the system level, establishing a population-based cancer registry and addressing residual iodine deficiency would provide the surveillance and prevention infrastructure that is currently lacking in the country.9,15 A prospective multicenter study with complete pathological data and a central review would allow these questions to be addressed. Conclusion In this first histopathological characterization of thyroidectomy specimens from Mogadishu, benign goitrous disease accounted for 366 of the 438 specimens, while 64 specimens (14.6%) were malignant, predominantly PTC. The surgical population was predominantly female (90%), and the proportion of specimens that proved malignant was greatest among patients aged 30 years or younger (22.2%) rather than in middle age, whereas malignancy did not differ significantly by sex. Borderline lesions were uncommon in eight specimens but became identifiable once the fifth edition of the WHO classification was applied and reassigning them altered the malignancy estimate only marginally. Among the malignant tumors, the median size was 3.0 cm, and most were categorized as T1 or T2, indicating disease that is resected at a measurable rather than incidental size. These findings establish a baseline for thyroid surgical pathology in settings where such data are largely absent. Because the cohort comprised only operated patients from a single referral laboratory and iodine status, thyroid function, and clinical outcomes were not available, the results describe the pattern of resected disease rather than population incidence or its causes. Within these limits, they support strengthening histopathological capacity, adopting standardized reporting aligned with the current WHO classification, and expanding preoperative fine-needle aspiration cytology to improve patient selection for surgery. Multicenter and prospective studies with complete pathological data and central reviews are needed to confirm these patterns and clarify the age distribution of malignancies in this population. Acknowledgment The author acknowledges the support of the Center of Research and Development (CRD), SIMAD University, Mogadishu, Somalia. Funding Statement The authors received no financial support for the research, authorship, or publication of this study. Declaration of AI Use The authors used Paperpal AI (web version, accessed August 2026) for language editing to improve clarity and readability. This assistance was limited to linguistic refinement only; study design, data analysis, interpretation, and all conclusions remain the responsibility of the authors. https://paperpal.com Data Sharing Statement The data supporting the findings of this study are available from the corresponding author. Ethical Approval and Consent to Participate The study was approved by the SIMAD University Institutional Review Board (Ref: EC000246) on May 18, 2026. The requirement for informed consent was waived because this retrospective study used existing, routinely generated histopathology records, involved no patient contact or intervention, and posed a minimal risk. All records were de-identified, assigned unique study codes, and stored on a password-protected computer accessible only to the investigators. No identifiable patient information is reported. Patient confidentiality was maintained throughout, and the study was conducted in accordance with the Declaration of Helsinki. Disclosure The authors declare no conflicts of interest. References Associated Data Data Availability Statement The data supporting the findings of this study are available from the corresponding author.